- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Staphylococcal Infections in New Zealand
Total 6535 results
-
Mylan Inc.Theravance BiopharmaCompleted
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Gilead SciencesCompletedHCV InfectionUnited States, New Zealand, Germany
-
University of California, IrvineHarvard Medical School (HMS and HSDM); National Institute of Allergy and Infectious... and other collaboratorsCompletedMethicillin Resistant Staphylococcus Aureus | Multi Drug Resistant Organisms | Healthcare Associated InfectionsUnited States
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Gilead SciencesCompletedHIVUnited States, New Zealand
-
Starship Child Health, Te Toka Tumai AucklandMenzies School of Health Research; Health Research Council, New ZealandNot yet recruitingRheumatic Fever | Sydenham ChoreaAustralia, New Zealand
-
James Cook University, Queensland, AustraliaNational Health and Medical Research Council, Australia; The Prince Charles... and other collaboratorsCompleted
-
Hoffmann-La RocheTerminatedHepatitis B Virus InfectionUnited Kingdom, Hong Kong, Korea, Republic of, Taiwan, Poland, Bulgaria, New Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BSingapore, Hong Kong, Bulgaria, Moldova, Republic of, New Zealand, Romania
-
NeuroActiva, Inc.Biomed Industries, Inc.UnknownCovid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)New Zealand, United States
-
Bristol-Myers SquibbCompletedSepsis | Candidemia | Staphylococcal Infections | Nosocomial InfectionsUnited States, Canada
-
Janssen Research & Development, LLCCompletedHepatitis BFrance, United States, Belgium, United Kingdom, Poland, New Zealand, Germany, Italy, Canada
-
Alnylam PharmaceuticalsTerminatedHepatitis B | Chronic Hepatitis B | Hepatitis B, Chronic | HBV | Hepatitis B InfectionUnited Kingdom, New Zealand, Singapore, Korea, Republic of, Australia, Hong Kong
-
Lyra TherapeuticsCompleted
-
Kirby InstituteCompletedDAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)Hepatitis CAustralia, New Zealand
-
Macfarlane Burnet Institute for Medical Research...St Vincent's Hospital MelbourneCompletedHepatitis CAustralia, New Zealand
-
Arbutus Biopharma CorporationCompletedHepatitis B, ChronicAustralia, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BNew Zealand, Bulgaria, Moldova, Republic of, Romania
-
Janssen Research & Development, LLCActive, not recruitingHepatitis B, ChronicFrance, Belgium, Italy, United Kingdom, Poland, Spain, New Zealand, Taiwan
-
ViiV HealthcareCompletedHIV InfectionsUnited States, New Zealand
-
Gilead SciencesCompletedHCV InfectionNew Zealand, United States, Puerto Rico
-
Zealand University HospitalHolbaek Sygehus; Chr Hansen; Dept. of Microbiology, Slagelse University Hospital... and other collaboratorsCompleted
-
Gilead SciencesCompletedHepatitis BKorea, Republic of, United States, Canada, Australia, New Zealand
-
Arrowhead PharmaceuticalsCompletedHepatitis BAustralia, Hong Kong, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicTaiwan, United States, New Zealand, Singapore
-
Hoffmann-La RocheCompletedHepatitis B, ChronicTaiwan, United States, New Zealand, Singapore
-
Alios Biopharma Inc.Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicAustralia, New Zealand
-
Janssen Research & Development, LLCTerminated
-
Murdoch Childrens Research InstituteRoyal Children's HospitalCompletedPrimary Immunodeficiency | Invasive Pneumococcal Disease, Protection Against | Invasive Pneumococcal Disease, Recurrent Isolated, 1 | Invasive Pneumococcal Disease, Recurrent Isolated, 2Australia, New Zealand
-
Hoffmann-La RocheRecruitingChronic Hepatitis BKorea, Republic of, United States, Thailand, Hong Kong, Spain, New Zealand, Bulgaria, Taiwan, France
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Gilead SciencesCompletedHepatitis B VirusUnited States, Germany, New Zealand
-
Gilead SciencesCompletedChronic HBV InfectionUnited States, New Zealand
-
Gilead SciencesActive, not recruitingChronic Hepatitis BTaiwan, New Zealand
-
Northwell HealthNext Science TMRecruitingJoint InfectionUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedChronic Hepatitis C Virus InfectionUnited States, New Zealand
-
AbbVieCompletedHepatic ImpairmentUnited States, New Zealand
-
Abivax S.A.CompletedChronic Hepatitis BNew Zealand, Australia
-
Gilead SciencesCompletedHepatitis C VirusUnited States, New Zealand
-
The Center for the Biology of Chronic DiseaseCompletedEpstein-Barr Virus Infections | Cytomegalovirus Infections | Human Papillomavirus | Herpes Simplex Infections | Varicella-zoster Virus InfectionUnited States
-
Alios Biopharma Inc.CompletedChronic Hepatitis BKorea, Republic of, Moldova, Republic of, New Zealand, Thailand, Ukraine
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
Regeneron PharmaceuticalsCompletedAllergyUnited Kingdom, New Zealand, Netherlands, Sweden
-
The University of QueenslandAustralasian Society for Infectious Diseases; International Society of Chemotherapy and other collaboratorsTerminatedBloodstream InfectionsAustralia, Singapore, South Africa, Italy, Saudi Arabia, Canada, Lebanon, New Zealand, Turkey
-
PfizerCompletedCOVID-19 | SARS-CoV-2 InfectionAustralia, New Zealand
-
AusperBio Therapeutics Inc.Active, not recruitingChronic Hepatitis BUnited States, Hong Kong, Taiwan, New Zealand
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsPanama, New Zealand, South Africa